ITGAL and neoplasm: In addition, given that LFA-1 blockade but not ICAM-1 deficiency/blockade affected the anti-tumor efficacy of adoptive T cell therapy, LFA-1 interactions with other ligands such as ICAM-2 seem to be sufficient to preserve T cell effector function.